OverviewSuggest Edit

    Neurolixis is an biopharmaceutical company. It focuses on the discovery and development of novel drugs for the treatment of human central nervous system disorders including Parkinson's disease, Rett syndrome, depression and schizophrenia.

    Latest Updates

    Employees (est.) (Mar 2020)3

    Neurolixis Financials and Metrics

    Summary Metrics

    Founding Date


    Neurolixis latest funding size

    $15 k
    Show all financial metrics

    Neurolixis Online and Social Media Presence

    Embed Graph

    Neurolixis Frequently Asked Questions

    • When was Neurolixis founded?

      Neurolixis was founded in 2011.

    • How many employees does Neurolixis have?

      Neurolixis has 3 employees.

    • Who are Neurolixis competitors?

      Competitors of Neurolixis include Acumen, EncepHeal Therapeutics and Newron Pharmaceuticals.